Randomised trials of 6 % tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis

被引：0
|
作者：
Amit Patel
Umeer Waheed
Stephen J. Brett
机构：
[1] Imperial College Healthcare NHS Trust,Centre for Perioperative Medicine and Critical Care Research
[2] Imperial College London,MRC Clinical Sciences Centre and Centre for Haematology
[3] Imperial College Healthcare NHS Trust,General Intensive Care Unit, Centre for Perioperative Medicine and Critical Care Research
来源：
Intensive Care Medicine | 2013年 / 39卷
关键词：
6 % tetrastarch; 6 % hydroxyethyl starch (HES) 130/0.4 or 0.42; Severe sepsis; Mortality; Renal;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：811 / 822
页数：11
相关论文
共 50 条
  • [1] Randomised trials of 6 % tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis
    Patel, Amit
    Waheed, Umeer
    Brett, Stephen J.
    [J]. INTENSIVE CARE MEDICINE, 2013, 39 (05) : 811 - 822
  • [2] Is 6% tetrastarch 130 kDa (hydroxyethyl starch 130/0.4 or 130/0.42) suitable for severe sepsis?
    Patel, Amit
    Brett, Stephen J.
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (03) : 178 - 178
  • [3] Sources of Heterogeneity in Trials Reporting Hydroxyethyl Starch 130/0.4 or 0.42 Associated Excess Mortality in Septic Patients: A Systematic Review and Meta-regression
    Ma Peng-Lin
    Peng Xiao-Xia
    Du Bin
    Hu Xiao-Lan
    Gong Yi-Chun
    Wang Yu
    Xi Xiu-Ming
    [J]. 中华医学杂志(英文版), 2015, (17) : 2374 - 2382
  • [4] Sources of Heterogeneity in Trials Reporting Hydroxyethyl Starch 130/0.4 or 0.42 Associated Excess Mortality in Septic Patients: A Systematic Review and Meta-regression
    Ma, Peng-Lin
    Peng, Xiao-Xia
    Du, Bin
    Hu, Xiao-Lan
    Gong, Yi-Chun
    Wang, Yu
    Xi, Xiu-Ming
    [J]. CHINESE MEDICAL JOURNAL, 2015, 128 (17) : 2374 - 2382
  • [5] Mortality after hydroxyethyl starch 130/0.4 infusion: an updated meta-analysis of randomized trials
    Wiedermann, Christian J.
    Joannidis, Michael
    [J]. SWISS MEDICAL WEEKLY, 2012, 142
  • [6] Low-quality Trials as a Source of Heterogeneity in the Association of Hydroxyethyl Starch 130/0.4 or 0.42 with Excess Mortality in Sepsis
    Wiedermann Christian J
    [J]. 中华医学杂志(英文版), 2016, (01) : 116 - 117
  • [7] Low-quality Trials as a Source of Heterogeneity in the Association of Hydroxyethyl Starch 130/0.4 or 0.42 with Excess Mortality in Sepsis
    Wiedermann, Christian J.
    [J]. CHINESE MEDICAL JOURNAL, 2016, 129 (01) : 116 - +
  • [8] Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.
    Patel, Amit
    Waheed, Umeer
    Brett, Stephen J.
    [J]. INTENSIVE CARE MEDICINE, 2013, 39 (08) : 1507 - 1508
  • [9] Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.
    Amit Patel
    Umeer Waheed
    Stephen J. Brett
    [J]. Intensive Care Medicine, 2013, 39 : 1507 - 1508
  • [10] Individual patient data meta-analysis of hydroxyethyl starch 130/0.4-0.42 versus crystalloid for fluid resuscitation in patients with severe sepsis: a statistical analysis plan
    Hammond, Naomi E.
    Haase, Nicolai
    Billot, Laurent
    Wetterslev, Jorn
    Saxena, Manoj K.
    Finfer, Simon
    Perner, Anders
    Myburgh, John
    [J]. CRITICAL CARE AND RESUSCITATION, 2014, 16 (02) : 96 - 103
12345